Simplex Trading
GYRE icon

Simplex Trading’s Gyre Therapeutics GYRE Stock Holding History

Simplex Trading’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.9K Sell
2,000
-100
-5% -$777 ﹤0.01% 7056
2025
Q4 		$14.8K Buy
+2,100
New +$16.2K ﹤0.01% 6727
2022
Q4 		– Sell
-720
Closed -$2K – 9648
2022
Q3 		$2K Buy
720
+107
+17% +$1.36K ﹤0.01% 9282
2022
Q2 		$8K Buy
+613
New +$4.07K ﹤0.01% 8462
2021
Q2 		– Sell
-60
Closed -$227K – 10273
2021
Q1 		$227K Buy
+60
New +$2.74K ﹤0.01% 4562
2020
Q3 		– Sell
-19
Closed -$82K – 8061
2020
Q2 		$82K Hold
19
– – ﹤0.01% 5004
2020
Q1 		$61K Buy
+19
New +$873 ﹤0.01% 4922
2019
Q4 		– Sell
-8
Closed -$335 – 6967
2019
Q3 		$30K Buy
+8
New +$431 ﹤0.01% 5492
2019
Q2 		– Sell
-13
Closed -$79K – 7371
2019
Q1 		$79K Buy
13
+9
+225% +$578 ﹤0.01% 4592
2018
Q4 		$26K Sell
4
-34
-89% -$2.51K ﹤0.01% 5125
2018
Q3 		$306K Sell
38
-67
-64% -$5.31K ﹤0.01% 3159
2018
Q2 		$917K Buy
105
+39
+59% +$6.84K ﹤0.01% 1878
2018
Q1 		$34K Buy
+66
New +$12.3K ﹤0.01% 2816
2017
Q2 		– Sell
-50
Closed -$130K – 6362
2017
Q1 		$130K Buy
+50
New +$2.92K 0.01% 1524
2015
Q3 		– Hold
0
– -$1K – 5759
2015
Q2 		– Hold
0
– – – 4663
2015
Q1 		– Hold
0
– – – 4481

Other funds holding GYRE

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Simplex Trading's GYRE Position: Q1 2026 in Review

Simplex Trading reduced its Gyre Therapeutics (GYRE) stake by 20% in Q1 2026, selling an estimated $1.28K and leaving 674 shares worth $4.7K. The position accounts for ﹤0.01% of the portfolio, ranked #7932.

Simplex Trading first reported a position in GYRE in Q1 2015 and has held it in 18 quarters since. The position peaked at $492K in Q2 2018. 56 funds tracked by Wall St. Rank hold GYRE as of Q1 2026.

  • Simplex Trading held 674 shares of Gyre Therapeutics worth $4.7K as of Q1 2026.
  • Simplex Trading sold 165 Gyre Therapeutics shares in Q1 2026, an estimated $1.28K.
  • Gyre Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #7932 holding.
  • Simplex Trading first reported a position in Gyre Therapeutics in Q1 2015 and has held it in 18 quarters since.
  • Simplex Trading's Gyre Therapeutics position peaked at $492K in Q2 2018.
  • 56 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.